R

Arcus Biosciences
D

RCUS

22.670
USD
0.24
(1.07%)
قبل الجلسة
حجم التداول
100
الربح لكل سهم
-4
العائد الربحي
-
P/E
-7
حجم السوق
2,804,925,911
أصول ذات صلة المقالات

العنوان: Arcus Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.